Molecular-guided decision-making improves disease control and remission in the treatment of IBD with anti-TNF therapy, however, application to other therapies is questioned.

Objective Growing evidence suggests that coeliac disease (CeD) is more common in patients with inflammatory bowel disease ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

An expert has recommended adding a portion of an anti-inflammatory food to your diet every week to reduce your risk of heart disease. This food has been shown to lower levels of fat in the blood ...

Please provide your email address to receive an email when new articles are posted on . Malnutrition adversely affects outcomes among patients with liver disease. Protein and fiber supplementation ...

The presentation, titled "Improving Patient Subtyping with AI-Driven Insights to Unlock Better Insights into IBD Heterogeneity & Smash the Efficacy Ceiling," will be led by Dr. Joerg Heyer ...

The Consortium Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) now publish data on the global prevalence of inflammatory bowel disease (IBD) in Nature. Researchers from ...

If you’re living with ulcerative colitis, testing may help identify which foods bother you, so that you can cut them out of your diet. Ulcerative colitis (UC) cannot cause a food allergy ...

His health was a major reason why. Renfrow was felled by ulcerative colitis, an inflammatory bowel disease that affects some 1.6 million people in the United States. 📲 Follow The Sporting News ...

Background IBD is a chronic inflammatory condition driven by complex genetic and immune interactions, yet preclinical models often fail to fully recapitulate all aspects of the human disease. A ...

Johnson & Johnson (J&J) has announced that its dual-acting IL-23 inhibitor Tremfya (guselkumab) has been approved by the European Commission (EC) to treat adults with ulcerative colitis (UC). Patients ...